Journal profile · Pharmacology & Pharmacy
Trends in Pharmacological Sciences
ISSN 0165-6147 · eISSN 1873-3735 · Elsevier Ltd · NETHERLANDS · Monthly
Trends in Pharmacological Sciences: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 23.13; hybrid open access; APC about USD 7,030; median 71 days to acceptance (102 articles, last 24 months); community-reported acceptance: mostly invited papers; 152 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Trends in Pharmacological Sciences is published by Elsevier Ltd and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Receptor Mechanisms and Signaling, Neuroscience and Neuropharmacology Research and Neuropeptides and Animal Physiology, together about 37.1% of its articles. Its main subfields are Molecular Biology and Cellular and Molecular Neuroscience. (generated from OpenAlex topic counts and CAS ranking data)
Trends in Pharmacological Sciences (TIPS) is a monthly peer-reviewed reviews journal that publishes reviews and opinions in fields broadly covering pharmacology, pharmacy, pharmaceutics and toxicology. Launched in 1979, every issue of TIPS contains succinct articles on the most exciting recent developments in pharmacology and therapeutics research. The major areas of research that TIPS is interested in are:Drug discovery and development (drug design, target identification and validation, lead generation, preclinical and clinical drug development, drug delivery, pharmaceutical formulation)Basic and clinical pharmacology (drug mechanisms, receptors, enzymes, ion channels, transporters, different classes of ligands, biomarkers, pharmacokinetics, pharmacodynamics, drug metabolism and pharmacogenetics)Therapeutics (gene- based, cell- based, protein-based therapy, other drug modalities, routes of administration, drug classes, drug nomenclature)Drug safety and toxicity (drug- drug interactions, adverse drug reactions, mechanisms of drug toxicity, pharmacovigilance)Pharmacy, pharmacoepidemiology and pharmacoeconomicsTIPS particularly seeks articles that are relevant to one or more of these themes. Additionally, TIPS welcomes articles on biopharma regulatory landscape, science policy and regulation and bioethics.Reviews and opinions published in TIPS are usually invited by the editor, Dr. Jerry Madukwe but we welcome suggestions from the community as well. Please contact tips@cell.com for more information.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editorial board by country: 1 in mainland China (about 4%); most named United States 11, Australia 5, United Kingdom 4, Sweden 2, Mainland China 1 (27 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology17.8%
- Neuroscience and Neuropharmacology ResearchNeuroscience10%
- Neuropeptides and Animal PhysiologyNeuroscience9.3%
- Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology6%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance5.7%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience5.3%
- Computational Drug Discovery MethodsComputer Science4.6%
- Nicotinic Acetylcholine Receptors StudyBiochemistry, Genetics and Molecular Biology3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
Top journal: yesReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
Top journal: yesReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 23.13LetPub ·
- Impact factor (publisher)
- 24Publisher website ·
- CiteScore 2026-06
- 32.4LetPub ·
- CiteScore (publisher)
- 32.4Publisher website ·
- SJR 2026-06
- 4.45LetPub ·
- SNIP 2026-06
- 3.78LetPub ·
- h-index
- 201LetPub ·
- h-index
- 322OpenAlex ·
- i10-index
- 4,234OpenAlex ·
- 2-year mean citedness
- 10.71OpenAlex ·
- Self-citation rate
- 0.4%LetPub ·
- Share of gold OA articles
- 29.65%LetPub ·
Volume
- Articles per year
- 73LetPub ·
Articles by year OpenAlex count · 7,596 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 115 | 34 | 86 |
| 2025 | 152 | 70 | 1,208 |
| 2024 | 140 | 76 | 3,064 |
| 2023 | 121 | 74 | 5,067 |
| 2022 | 126 | 76 | 4,924 |
| 2021 | 124 | 76 | 7,204 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
71 daysMedian, submission to acceptance · P25–P75 34 days – 97 days
- Acceptance to online
- median 24 days (102 articles)
- Submission to online
- median 96 days
- Sample
- 102 articles with submission and acceptance dates (253 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Mostly invited papersLetPub ·
- Submission to first decision
- 1 daysPublisher website ·
- Submission to acceptance
- 50 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 7,030 / EUR 6,510 / GBP 5,630 / JPY 871,930 | — | — | |
| Publisher website | USD 7,030 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open Access
Article Publishing Charge (APC): USD 7,030 (excluding taxes). The amount you pay may be reduced during submission if applicable.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Ltd
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Monthly
- ISSN
- 0165-6147
- Electronic ISSN
- 1873-3735
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Trends in Pharmacological Sciences
What CAS zone is Trends in Pharmacological Sciences in?
In the 2025 upgraded edition of the CAS Journal Ranking, Trends in Pharmacological Sciences is in Zone 1 of Medicine, and in Zone 1 of the minor category Pharmacology & Pharmacy; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Trends in Pharmacological Sciences?
The latest impact factor listed by LetPub is 23.13; CiteScore 32.4, h-index 322.
How long does peer review take at Trends in Pharmacological Sciences?
Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 71 days (interquartile range 34–97 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Mostly invited papers”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Trends in Pharmacological Sciences based?
Of the 27 board members whose country the journal's board page names, 1 (about 4%) are in mainland China; the countries named most often are United States (11), Australia (5) and United Kingdom (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Trends in Pharmacological Sciences?
According to LetPub and DOAJ records, Trends in Pharmacological Sciences is indexed in SCIE and Scopus.
Is Trends in Pharmacological Sciences open access, and what is the APC?
Trends in Pharmacological Sciences is a hybrid journal. For open-access publication: APC about USD 7,030.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .